TP53 mutations at codon 234 are associated with chlorambucil treatment in chronic lymphocytic leukemia

Am J Hematol. 2022 Apr;97(4):E159-E162. doi: 10.1002/ajh.26479. Epub 2022 Feb 1.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Chlorambucil* / therapeutic use
  • Codon
  • Humans
  • Leukemia, Lymphocytic, Chronic, B-Cell* / drug therapy
  • Leukemia, Lymphocytic, Chronic, B-Cell* / genetics
  • Mutation
  • Tumor Suppressor Protein p53* / genetics

Substances

  • Codon
  • TP53 protein, human
  • Tumor Suppressor Protein p53
  • Chlorambucil